Hemogenyx secures clearance for pediatric enrolment in leukemia trial
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More
Price | 1,000.00p on 20-10-2025 | at 18:50:06
---|---|
Change | 32.00p 3.31% |
Buy | 1,020.00p |
Sell | 960.00p |
Last Trade: | Buy 30.00 at 1,000.00p |
Day's Volume: | 13,889 |
Last Close: | 1,000.00p |
Open: | 1,000.00p |
ISIN: | GB00BQVXM815 |
Day's Range | 942.00p - 1,020.00p |
52wk Range: | 0.876p - 1,790.00p |
Market Capitalisation: | £53.61m |
VWAP: | 988.86744p |
Shares in Issue: | 5.36m |
Sector: Medicine and Biotech
Hemogenyx Pharmaceuticals (HEMO) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 30 | 1,000.00p | Suspected BUY Trade |
16:35:01 - 20-Oct-25 |
Sell* | 32 | 984.80p | Ordinary |
16:29:17 - 20-Oct-25 |
Unknown* | 0 | 1,020.00p | SI Trade |
16:28:41 - 20-Oct-25 |
Buy* | 8 | 1,020.00p | SI Trade |
16:28:41 - 20-Oct-25 |
Sell* | 9 | 960.00p | SI Trade |
16:28:41 - 20-Oct-25 |
Buy* | 136 | 1,015.125p | Ordinary |
16:04:59 - 20-Oct-25 |
Buy* | 48 | 1,015.125p | Ordinary |
15:59:59 - 20-Oct-25 |
Buy* | 99 | 1,002.3072p | Ordinary |
15:52:18 - 20-Oct-25 |
Sell* | 140 | 984.036p | Ordinary |
15:37:40 - 20-Oct-25 |
Sell* | 100 | 983.40p | Ordinary |
15:35:59 - 20-Oct-25 |
Hemogenyx Pharmaceuticals (HEMO) Regulatory News |
||
Date | Source | Headline |
---|---|---|
6th Oct 2025 7:00 am | RNS | Clearance to Initiate Pediatric Enrolment |
30th Sep 2025 7:00 am | RNS | Half-year Report |
30th Sep 2025 7:00 am | RNS | Total Voting Rights |
23rd Sep 2025 7:00 am | RNS | Hemogenyx Signs Letter of Intent |
18th Sep 2025 1:16 pm | RNS | Holding(s) in Company |
17th Sep 2025 7:00 am | RNS | Third Patient Safety |
11th Sep 2025 7:00 am | RNS-R | Invitation to Participate at DCNY Summit |
8th Sep 2025 7:00 am | RNS | Manufacturing Partnership with Made Scientific |
5th Sep 2025 7:00 am | RNS | Exercise of Warrants and Issue of Equity |
3rd Sep 2025 1:57 pm | RNS | Exercise of Warrants and Issue of Equity |